| CTPS |
CTPS: CTP synthase 1 |
CASP9 |
CASP9, MCH6: Caspase-9 precursor |
3.34 |
Evidence |
|
| PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
3.34 |
Evidence |
|
| PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
FADD |
FADD, MORT1: Protein FADD |
3.34 |
Evidence |
|
| PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
3.34 |
Evidence |
|
| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
GUCA2A |
GUCA2A, GUCA2: Guanylin precursor |
3.34 |
Evidence |
|
| UBTF |
UBTF, UBF, UBF1: Nucleolar transcription factor 1 |
MKNK1 |
MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 |
3.34 |
Evidence |
|
| UBTF |
UBTF, UBF, UBF1: Nucleolar transcription factor 1 |
RPS6KA2 |
RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 |
3.34 |
Evidence |
|
| ZFX |
ZFX: Zinc finger X-chromosomal protein |
SEC13L1 |
IPI00375370 |
3.34 |
Evidence |
|
| MGMT |
MGMT: Methylated-DNA--protein-cysteine methyltransferase |
DUSP6 |
DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 |
3.34 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
CDC42 |
IPI00016786 |
3.34 |
Evidence |
|
| H2AFX |
H2AFX, H2AX: Histone H2A.x |
JDP2 |
jdp2, JDP2: Jun dimerization protein 2 |
3.34 |
Evidence |
|
| H2AFX |
H2AFX, H2AX: Histone H2A.x |
AR |
AR, DHTR, NR3C4: Androgen receptor |
3.34 |
Evidence |
|
| H2AFX |
H2AFX, H2AX: Histone H2A.x |
IRF7 |
IPI00298041 |
3.34 |
Evidence |
|
| H2AFX |
H2AFX, H2AX: Histone H2A.x |
MAPK9 |
MAPK9, JNK2, PRKM9: Mitogen-activated protein kinase 9 |
3.34 |
Evidence |
|
| H2AFX |
H2AFX, H2AX: Histone H2A.x |
CUTL1 |
CUTL1: Homeobox protein cut-like 1 |
3.34 |
Evidence |
|
| TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
JDP2 |
jdp2, JDP2: Jun dimerization protein 2 |
3.34 |
Evidence |
|
| TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
AR |
AR, DHTR, NR3C4: Androgen receptor |
3.34 |
Evidence |
|
| TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
NEK6 |
NEK6: Serine/threonine-protein kinase Nek6 |
3.34 |
Evidence |
|
| TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
IRF7 |
IPI00298041 |
3.34 |
Evidence |
|
| TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
NFATC2 |
NFATC2, NFAT1, NFATP: Nuclear factor of activated T-cells, cytoplasmic 2 |
3.34 |
Evidence |
|
| BRAF |
BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase |
FBXO4 |
FBXO4, FBX4: F-box only protein 4 |
3.34 |
Evidence |
|
| JUP |
JUP, CTNNG, DP3: Junction plakoglobin |
SGK2 |
SGK2: Serine/threonine-protein kinase Sgk2 |
3.34 |
Evidence |
|
| JUP |
JUP, CTNNG, DP3: Junction plakoglobin |
DYRK1A |
DYRK1A, DYRK, MNB, MNBH: Dual specificity tyrosine-phosphorylation-regulated kin |
3.34 |
Evidence |
|
| SNRPB |
IPI00395674 |
LSM3 |
LSM3, MDS017: U6 snRNA-associated Sm-like protein LSm3 |
3.34 |
Evidence |
|
| NCF1 |
Neutrophil cytosolic factor 1 variant (Fragment) |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
3.34 |
Evidence |
|